Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: NDMA briefing

This article was originally published in The Tan Sheet

Executive Summary

NDMA briefing: The Nonprescription Drug Manufacturers Association will hold a Dec. 3 briefing on the FDA reform bills recently passed in the House and Senate. The bills are awaiting discussion in conference before being forwarded to the President. The focus of the meeting will be on the national uniformity and OTC records inspection provisions in the legislation. FDA District Director New Jersey District Douglas Ellsworth is tentatively scheduled to speak. Other speakers will include McNeil Consumer Products Director of Contract Operations and New Business Donald Cadge and Bruce Cuhlik, Covington & Burling. FDA has indicated the increased inspection authorities authorized under the bill would significantly alter its approach to OTC inspections ("The Tan Sheet" Oct. 20, p. 25). The meeting will be held at the Newark, N.J. Airport Marriott and is scheduled to run from 9 a.m. to 1 p.m. A closed session, involving industry participants only, will start at 11 a.m...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087725

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel